Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement

Lupus

Volumn 20, Issue 8, 2011, Pages 845-854

  Ezzat, M H M ^a   EL Gammasy, T M A ^a   Shaheen, K Y A ^a   Shokr, E S M ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Anti double stranded DNA; B cell attracting chemokine 1; CXCL13; Nephritis; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CXCL13 CHEMOKINE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA; PREDNISOLONE; STEROID;

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CHILDHOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG PULSE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; AGE OF ONSET; ANIMALS; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; CHEMOKINE CXCL13; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MICE; SEVERITY OF ILLNESS INDEX;

EID: 80052775661     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311398513     Document Type: Article

References (26)

1. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B-cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998; 187: 655-660. (Pubitemid 28093368)
2. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998; 391: 799-803. (Pubitemid 28099679)
3. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002; 16: 67-76. (Pubitemid 34143217)
4. Huber TB, Reinhardt HC, Exner M, et al. Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol 2002; 168: 6244-6252. (Pubitemid 34620044)
5. Jenh CH, Cox MA, Hipkin W, et al. Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor. Cytokine 2001; 15: 113-121. (Pubitemid 34587493)
6. Okada T, Ngo VN, Ekland EH, et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002; 196: 65-75. (Pubitemid 34747312)
7. Reif K, Ekland EH, Ohl L, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002; 416: 94-99. (Pubitemid 34215407)
8. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000; 192: 1553-1562.
9. Tucker LB, Uribe AG, Fernández M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008; 17: 314-322. (Pubitemid 351655799)
10. Costenbader KH, Karlson EW, Liang MH, Mandl LA. Defining lupus cases for clinical studies: The Boston Weighted Criteria for the Classification of Systemic Lupus Erythematosus. J Rheumatol 2002; 29: 2545-2550. (Pubitemid 35416959)
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, for the Committee on prognosis studies in SLE. Derivation of the SLEDAI. A diseases activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
12. Gilkeson G, Canon C, Oates J, Reily C, Goldman D, Petri M. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999; 26: 318-324. (Pubitemid 29066735)
13. Gonzalez-Crespo MR, Navarro JA, Arenas J, Martin Mola E, De La Cruz J, Gomez-Reino JJ. Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus. Br J Rheumatol 1998; 37: 972-977.
14. Duan B, Niu H, Xu Z, et al. Intrafollicular location of marginal zone/CD1d (hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Lab Invest 2008; 88: 1008-1020.
15. Ishikawa S. Aberrant high expression of B lymphocyte chemoattractant (BLC/CXCL13) in a murine model for SLE. Tanpakushitsu Kakusan Koso 2002; 47: 2369-2374.
16. Ishikawa S, Matsushima K. Aberrant B1 cell trafficking in a murine model for lupus. Front Biosci 2007; 12: 1790-1803. (Pubitemid 46846807)
17. Lee HT, Shiao YM, Wu TH, et al. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol 2010; 37: 45-52.
18. Rovin BH. The chemokine network in systemic lupus erythematous nephritis. Front Biosci 2008; 13: 904-922. (Pubitemid 351594736)
19. Schiffer L, Kumpers P, Davalos-Misslitz AM, et al. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus. Nephrol Dial Transplant 2009; 24: 3708-3712.
20. Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol 2010; 30: 45-52.
21. Bhat P, Radhakrishnan JB. lymphocytes and lupus nephritis: new insights into pathogenesis and targeted therapies. Kidney Int 2008; 73: 261-268.
22. Van-Vollenhoven RF. Dehydroepiandrosterone in systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 349-362.
23. Buc M, Rovensky J. Systemic lupus erythematosus-a contemporary view of its genetic determination, immunopathogenesis and therapy. Epidemiol Mikrobiol Imunol 2009; 58: 3-14.
24. Yung S, Chan TM. Anti-DNA antibodies in the pathogenesis of lupus nephritis-the emerging mechanisms. Autoimmun Rev 2008; 7: 317-321.
25. Steinmetz OM, Stahl RA, Panzer U. Chemokines and B cells in renal inflammation and allograft rejection. Front Biosci (Schol Ed) 2009; 1: 13-22.
26. Nakashima H, Akahoshi M, Masutani K. Th1/Th2 balance of SLE patients with lupus nephritis. Rinsho Byori 2006; 54: 706-713.